Skip to main content

PRECIGEN INC

For the period ended Dec 31, 2023. Filed Mar 19, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 19, 2024

PGEN$4.73+5.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 19, 2024

PRECIGEN, INC.
By:/S/ HELEN SABZEVARI
Helen SabzevariChief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/S/ HELEN SABZEVARIChief Executive Officer and Director(Principal Executive Officer)3/19/2024
Helen Sabzevari
/S/ HARRY THOMASIAN JR.Chief Financial Officer(Principal Accounting and Financial Officer)3/19/2024
Harry Thomasian Jr.
/S/ RANDAL J. KIRKExecutive Chairman3/19/2024
Randal J. Kirk
/S/ CESAR L. ALVAREZDirector3/19/2024
Cesar L. Alvarez
/S/ STEVEN FRANKDirector3/19/2024
Steven Frank
/S/ VINITA D. GUPTADirector3/19/2024
Vinita D. Gupta
/S/ FRED HASSANDirector3/19/2024
Fred Hassan
/S/ JEFFREY B. KINDLERDirector3/19/2024
Jeffrey B. Kindler
/S/ DEAN J. MITCHELLDirector3/19/2024
Dean J. Mitchell
/S/ JAMES S. TURLEYDirector3/19/2024
James S. Turley

Index to the Financial Statements and Schedules

Page(s)
Consolidated Financial Statements of Precigen, Inc. and SubsidiariesF-2
Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34)F-3
Consolidated Balance Sheets as of December 31, 2023 and 2022F-5
Consolidated Statements of Operations for the Years Ended December 31, 2023, 2022, and 2021F-7
Consolidated Statements of Comprehensive Income (loss) for the Years Ended December 31, 2023, 2022, and 2021F-8
Consolidated Statements of Shareholders' and Total Equity for the Years Ended December 31, 2023, 2022, and 2021F-9
Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022, and 2021F-12
Notes to the Consolidated Financial StatementsF-15
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.